APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tumor Gene Test Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tumor Gene Test Service Market Analysis and Forecast 2026-2032

Report ID 17426097022 January 2026193 pages

Choose your research edition.

Industry ResearchTumor Gene Test Service Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Gene Test Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tumor Gene Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Gene Test Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Gene Test Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tumor Gene Test Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Tumor Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tumor Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tumor Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tumor Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Tumor Gene Test Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Tumor Gene Test Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tumor Gene Test Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Tumor Gene Test Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tumor Gene Test Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tumor Gene Test Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Tumor Gene Test Service revenue, projected growth trends, production technology, application and end-user industry.

Tumor Gene Test Service Segment by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

10x Genomics

QIAGEN

GEEWIZ

MACROGEN

Oxford Nanopore Technologies

Tumor Gene Test Service Segment by Type

Tumor Tissue

Blood

Tumor Gene Test Service Segment by Application

Medical Institution

Scientific Research Institutions

Pharmaceutical Companies

Individual User

Tumor Gene Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Gene Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Tumor Gene Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Tumor Gene Test Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Gene Test Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Gene Test Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tumor Tissue Major Player Table 3. Blood Major Player Table 4. Global Tumor Gene Test Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Institution Major Player Table 6. Scientific Research Institutions Major Player Table 7. Pharmaceutical Companies Major Player Table 8. Individual User Major Player Table 9. Tumor Gene Test Service Industry Trends Table 10. Tumor Gene Test Service Industry Drivers Table 11. Tumor Gene Test Service Industry Opportunities and Challenges Table 12. Tumor Gene Test Service Industry Restraints Table 13. Global Tumor Gene Test Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Tumor Gene Test Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Tumor Gene Test Service Market Share by Region (2021-2026) Table 16. Global Tumor Gene Test Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Tumor Gene Test Service Market Share by Region (2027-2032) Table 18. Global Tumor Gene Test Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Tumor Gene Test Service Revenue Market Share by Players (2021-2026) Table 20. Global Tumor Gene Test Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Tumor Gene Test Service Key Players Headquarters & Area Served Table 22. Global Tumor Gene Test Service Players, Product Type & Application Table 23. Global Tumor Gene Test Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Tumor Gene Test Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Tumor Gene Test Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Tumor Gene Test Service Revenue Market Share by Type (2021-2026) Table 30. Global Tumor Gene Test Service Revenue Market Share by Type (2027-2032) Table 31. Global Tumor Gene Test Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Tumor Gene Test Service Revenue Market Share by Application (2021-2026) Table 35. Global Tumor Gene Test Service Revenue Market Share by Application (2027-2032) Table 36. Illumina Company Information Table 37. Illumina Business Overview Table 38. Illumina Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Illumina Tumor Gene Test Service Product Portfolio Table 40. Illumina Recent Development Table 41. BGI Genomics Co.,Ltd. Company Information Table 42. BGI Genomics Co.,Ltd. Business Overview Table 43. BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio Table 45. BGI Genomics Co.,Ltd. Recent Development Table 46. Agilent Technologies Company Information Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Agilent Technologies Tumor Gene Test Service Product Portfolio Table 50. Agilent Technologies Recent Development Table 51. Macrogen Company Information Table 52. Macrogen Business Overview Table 53. Macrogen Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Macrogen Tumor Gene Test Service Product Portfolio Table 55. Macrogen Recent Development Table 56. Pacific Biosciences Company Information Table 57. Pacific Biosciences Business Overview Table 58. Pacific Biosciences Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pacific Biosciences Tumor Gene Test Service Product Portfolio Table 60. Pacific Biosciences Recent Development Table 61. 10x Genomics Company Information Table 62. 10x Genomics Business Overview Table 63. 10x Genomics Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. 10x Genomics Tumor Gene Test Service Product Portfolio Table 65. 10x Genomics Recent Development Table 66. QIAGEN Company Information Table 67. QIAGEN Business Overview Table 68. QIAGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. QIAGEN Tumor Gene Test Service Product Portfolio Table 70. QIAGEN Recent Development Table 71. GEEWIZ Company Information Table 72. GEEWIZ Business Overview Table 73. GEEWIZ Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GEEWIZ Tumor Gene Test Service Product Portfolio Table 75. GEEWIZ Recent Development Table 76. MACROGEN Company Information Table 77. MACROGEN Business Overview Table 78. MACROGEN Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. MACROGEN Tumor Gene Test Service Product Portfolio Table 80. MACROGEN Recent Development Table 81. Oxford Nanopore Technologies Company Information Table 82. Oxford Nanopore Technologies Business Overview Table 83. Oxford Nanopore Technologies Tumor Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio Table 85. Oxford Nanopore Technologies Recent Development Table 86. North America Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Tumor Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Tumor Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Tumor Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Tumor Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 100. China Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 101. China Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 102. China Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 103. China Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Tumor Gene Test Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Tumor Gene Test Service Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Tumor Gene Test Service Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Tumor Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Tumor Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Tumor Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Tumor Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Tumor Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Tumor Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Tumor Gene Test Service Image Figure 2. Global Tumor Gene Test Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Gene Test Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tumor Tissue Image Figure 5. Blood Image Figure 6. Global Tumor Gene Test Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tumor Gene Test Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Institution Image Figure 9. Scientific Research Institutions Image Figure 10. Pharmaceutical Companies Image Figure 11. Individual User Image Figure 12. Global Tumor Gene Test Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Tumor Gene Test Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Tumor Gene Test Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Tumor Gene Test Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Tumor Gene Test Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Tumor Gene Test Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Tumor Gene Test Service Revenue Market Share by Type (2021-2032) Figure 20. Global Tumor Gene Test Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Tumor Gene Test Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Tumor Gene Test Service Revenue Market Share by Application (2021-2032) Figure 23. North America Tumor Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Tumor Gene Test Service Revenue Share by Type (2021-2032) Figure 25. North America Tumor Gene Test Service Revenue Share by Application (2021-2032) Figure 26. North America Tumor Gene Test Service Revenue Share by Country (2021-2032) Figure 27. United States Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Tumor Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Tumor Gene Test Service Revenue Share by Type (2021-2032) Figure 32. Europe Tumor Gene Test Service Revenue Share by Application (2021-2032) Figure 33. Europe Tumor Gene Test Service Revenue Share by Country (2021-2032) Figure 34. Germany Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Tumor Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Tumor Gene Test Service Revenue Share by Type (2021-2032) Figure 44. China Tumor Gene Test Service Revenue Share by Application (2021-2032) Figure 45. Asia Tumor Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Tumor Gene Test Service Revenue Share by Type (2021-2032) Figure 47. Asia Tumor Gene Test Service Revenue Share by Application (2021-2032) Figure 48. Asia Tumor Gene Test Service Revenue Share by Region (2021-2032) Figure 49. Japan Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Tumor Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Tumor Gene Test Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Tumor Gene Test Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Tumor Gene Test Service Revenue Share by Country (2021-2032) Figure 59. Brazil Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Tumor Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor Tissue
  • Blood
Applications
  • Medical Institution
  • Scientific Research Institutions
  • Pharmaceutical Companies
  • Individual User
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • Oxford Nanopore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tumor Gene Test Service Market by Type
  3. 1.2.1 Global Tumor Gene Test Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tumor Tissue
  5. 1.2.3 Blood
  6. 1.3 Tumor Gene Test Service Market by Application
  7. 1.3.1 Global Tumor Gene Test Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Institution
  9. 1.3.3 Scientific Research Institutions
  10. 1.3.4 Pharmaceutical Companies
  11. 1.3.5 Individual User
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Tumor Gene Test Service Market Dynamics
  1. 2.1 Tumor Gene Test Service Industry Trends
  2. 2.2 Tumor Gene Test Service Industry Drivers
  3. 2.3 Tumor Gene Test Service Industry Opportunities and Challenges
  4. 2.4 Tumor Gene Test Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Tumor Gene Test Service Market Perspective (2021-2032)
  2. 3.2 Global Tumor Gene Test Service Growth Trends by Region
  3. 3.2.1 Global Tumor Gene Test Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tumor Gene Test Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Tumor Gene Test Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Tumor Gene Test Service Revenue by Players
  2. 4.1.1 Global Tumor Gene Test Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Tumor Gene Test Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Tumor Gene Test Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tumor Gene Test Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Tumor Gene Test Service Key Players Headquarters & Area Served
  7. 4.4 Global Tumor Gene Test Service Players, Product Type & Application
  8. 4.5 Global Tumor Gene Test Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Tumor Gene Test Service Market CR5 and HHI
  11. 4.6.3 2025 Tumor Gene Test Service Tier 1, Tier 2, and Tier 3
5 Tumor Gene Test Service Market Size by Type
  1. 5.1 Global Tumor Gene Test Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 5.3 Global Tumor Gene Test Service Revenue Market Share by Type (2021-2032)
6 Tumor Gene Test Service Market Size by Application
  1. 6.1 Global Tumor Gene Test Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Tumor Gene Test Service Revenue by Application (2021-2032)
  3. 6.3 Global Tumor Gene Test Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Tumor Gene Test Service Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 BGI Genomics Co.,Ltd.
  8. 7.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 7.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 7.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BGI Genomics Co.,Ltd. Tumor Gene Test Service Product Portfolio
  12. 7.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 7.3 Agilent Technologies
  14. 7.3.1 Agilent Technologies Company Information
  15. 7.3.2 Agilent Technologies Business Overview
  16. 7.3.3 Agilent Technologies Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Tumor Gene Test Service Product Portfolio
  18. 7.3.5 Agilent Technologies Recent Developments
  19. 7.4 Macrogen
  20. 7.4.1 Macrogen Company Information
  21. 7.4.2 Macrogen Business Overview
  22. 7.4.3 Macrogen Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Macrogen Tumor Gene Test Service Product Portfolio
  24. 7.4.5 Macrogen Recent Developments
  25. 7.5 Pacific Biosciences
  26. 7.5.1 Pacific Biosciences Company Information
  27. 7.5.2 Pacific Biosciences Business Overview
  28. 7.5.3 Pacific Biosciences Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pacific Biosciences Tumor Gene Test Service Product Portfolio
  30. 7.5.5 Pacific Biosciences Recent Developments
  31. 7.6 10x Genomics
  32. 7.6.1 10x Genomics Company Information
  33. 7.6.2 10x Genomics Business Overview
  34. 7.6.3 10x Genomics Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 10x Genomics Tumor Gene Test Service Product Portfolio
  36. 7.6.5 10x Genomics Recent Developments
  37. 7.7 QIAGEN
  38. 7.7.1 QIAGEN Company Information
  39. 7.7.2 QIAGEN Business Overview
  40. 7.7.3 QIAGEN Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QIAGEN Tumor Gene Test Service Product Portfolio
  42. 7.7.5 QIAGEN Recent Developments
  43. 7.8 GEEWIZ
  44. 7.8.1 GEEWIZ Company Information
  45. 7.8.2 GEEWIZ Business Overview
  46. 7.8.3 GEEWIZ Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GEEWIZ Tumor Gene Test Service Product Portfolio
  48. 7.8.5 GEEWIZ Recent Developments
  49. 7.9 MACROGEN
  50. 7.9.1 MACROGEN Company Information
  51. 7.9.2 MACROGEN Business Overview
  52. 7.9.3 MACROGEN Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MACROGEN Tumor Gene Test Service Product Portfolio
  54. 7.9.5 MACROGEN Recent Developments
  55. 7.10 Oxford Nanopore Technologies
  56. 7.10.1 Oxford Nanopore Technologies Company Information
  57. 7.10.2 Oxford Nanopore Technologies Business Overview
  58. 7.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Oxford Nanopore Technologies Tumor Gene Test Service Product Portfolio
  60. 7.10.5 Oxford Nanopore Technologies Recent Developments
8 North America
  1. 8.1 North America Tumor Gene Test Service Revenue (2021-2032)
  2. 8.2 North America Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Tumor Gene Test Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Tumor Gene Test Service Revenue by Type (2027-2032)
  5. 8.3 North America Tumor Gene Test Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Tumor Gene Test Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Tumor Gene Test Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Tumor Gene Test Service Revenue by Application (2027-2032)
  9. 8.5 North America Tumor Gene Test Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Tumor Gene Test Service Revenue by Country
  11. 8.6.1 North America Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Tumor Gene Test Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Tumor Gene Test Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Tumor Gene Test Service Revenue (2021-2032)
  2. 9.2 Europe Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Tumor Gene Test Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Tumor Gene Test Service Revenue by Type (2027-2032)
  5. 9.3 Europe Tumor Gene Test Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Tumor Gene Test Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Tumor Gene Test Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Tumor Gene Test Service Revenue by Application (2027-2032)
  9. 9.5 Europe Tumor Gene Test Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Tumor Gene Test Service Revenue by Country
  11. 9.6.1 Europe Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Tumor Gene Test Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Tumor Gene Test Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Tumor Gene Test Service Revenue (2021-2032)
  2. 10.2 China Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 10.2.1 China Tumor Gene Test Service Revenue by Type (2021-2026)
  4. 10.2.2 China Tumor Gene Test Service Revenue by Type (2027-2032)
  5. 10.3 China Tumor Gene Test Service Revenue Share by Type (2021-2032)
  6. 10.4 China Tumor Gene Test Service Revenue by Application (2021-2032)
  7. 10.4.1 China Tumor Gene Test Service Revenue by Application (2021-2026)
  8. 10.4.2 China Tumor Gene Test Service Revenue by Application (2027-2032)
  9. 10.5 China Tumor Gene Test Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tumor Gene Test Service Revenue (2021-2032)
  2. 11.2 Asia Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Tumor Gene Test Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Tumor Gene Test Service Revenue by Type (2027-2032)
  5. 11.3 Asia Tumor Gene Test Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Tumor Gene Test Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Tumor Gene Test Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Tumor Gene Test Service Revenue by Application (2027-2032)
  9. 11.5 Asia Tumor Gene Test Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Tumor Gene Test Service Revenue by Country
  11. 11.6.1 Asia Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Tumor Gene Test Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Tumor Gene Test Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tumor Gene Test Service Revenue (2021-2032)
  2. 12.2 SAMEA Tumor Gene Test Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Tumor Gene Test Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Tumor Gene Test Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Tumor Gene Test Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Tumor Gene Test Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Tumor Gene Test Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Tumor Gene Test Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Tumor Gene Test Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Tumor Gene Test Service Revenue by Country
  11. 12.6.1 SAMEA Tumor Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Tumor Gene Test Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Tumor Gene Test Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst